Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.618
Bid: 1.618
Ask: 1.622
Change: 0.008 (0.50%)
Spread: 0.004 (0.247%)
Open: 1.646
High: 1.646
Low: 1.596
Prev. Close: 1.61
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Separate Results

11 May 2017 07:00

RNS Number : 7803E
Commercial Intnl Bank (Egypt) SAE
11 May 2017
 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/7803E_-2017-5-10.pdf

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

March 31st, 2017

FINANCIAL POSITION

As of March 31st, 2017

Amounts in EGP Thousands

Note

March 31, 2017

 

December 31, 2016

 

Assets

Cash and balances with central bank

15

15,101,163

10,522,040

Due from banks

16

65,449,817

58,011,034

Treasury bills and other governmental notes

17

39,956,034

39,177,184

Trading financial assets

18

2,209,221

2,445,134

Loans and advances to banks, net

19

69,384

159,651

Loans and advances to customers, net

20

86,670,859

85,991,914

Derivative financial instruments

21

95,242

269,269

Financial investments

- Available for sale

22

5,139,805

5,447,291

- Held to maturity

22

49,389,060

53,924,936

Investments in associates

23

10,500

10,500

Non current assets held for sale

42

239,875

428,011

Other assets

24

6,241,609

5,446,025

Intangible assets

41

466,579

499,131

Deferred tax assets (Liabilities)

32

195,918

181,308

Property, plant and equipment

25

1,402,583

1,338,629

Total assets

272,637,649

263,852,057

Liabilities and equity

Liabilities

Due to banks

26

2,598,068

3,008,996

Due to customers

27

239,730,858

231,965,312

Derivative financial instruments

21

163,896

331,091

Dividends Payable

576,933

-

Current tax liabilities

598,735

2,017,034

Other liabilities

29

5,204,188

3,579,330

Long term loans

28

155,218

160,243

Other provisions

30

1,603,192

1,514,057

Total liabilities

250,631,088

242,576,063

Equity

Issued and paid up capital

31

11,538,660

11,538,660

Reserves

34

8,261,895

3,443,319

Reserve for employee stock ownership plan (ESOP)

420,564

343,460

Total equity

20,221,119

15,325,439

Net profit for the period/year

1,785,442

5,950,555

Total equity and net profit for the period/ year

22,006,561

21,275,994

Total liabilities and equity

272,637,649

263,852,057

INCOME STATEMENT

As of March 31, 2017

Amounts in EGP Thousands

Note

March 31, 2017

 

March 31, 2016

 

Interest and similar income

6,376,570

4,178,859

Interest and similar expense

(3,593,103)

(1,910,574)

Net interest income

6

2,783,467

2,268,285

Fee and commission income

647,861

463,058

Fee and commission expense

(130,060)

(83,981)

Net fee and commission income

7

517,801

379,077

Dividend income

8

1,799

492

Net trading income

9

386,603

107,642

Profits on financial investments

22

323,473

91,474

Administrative expenses

10

(746,457)

(601,548)

Other operating (expenses) income

11

(357,997)

(161,400)

Goodwill impairment

41

-

(10,854)

Intangible assets amortization

41

(32,552)

(32,552)

Impairment charge for credit losses

12

(506,570)

(287,613)

Profit before income tax

2,369,567

1,753,003

Income tax expense

13

(598,735)

(482,726)

Deferred tax assets (Liabilities)

32 & 13

14,610

58,435

Net profit for the year

1,785,442

1,328,712

Earnings per share

14

Basic

1.37

1.02

Diluted

1.35

1.00

CASH FLOW STATEMENT

As of March 31, 2016

 

 

 

Amounts in EGP Thousands

 

March 31, 2017

March 31, 2016

Cash flow from operating activities

Profit before income tax

2,369,567

1,753,003

 

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

84,592

64,951

Impairment charge for credit losses

506,570

287,613

Other provisions charges

88,440

23,622

Trading financial investments revaluation differences

(49,057)

195,000

Available for sale and held to maturity investments exchange revaluation differences

16,596

(263,567)

Goodwill impairment

-

10,854

Intangible assets amortization

32,552

32,552

Financial investments impairment charge

(59,574)

19,481

Utilization of other provisions

(358)

(470)

Other provisions no longer used

(2,470)

(33,132)

Exchange differences of other provisions

3,523

62,934

Profits from selling property, plant and equipment

-

(164)

Profits from selling financial investments

53,608

(16,259)

Profits (losses) from selling associates

-

(84,934)

Shares based payments

77,104

48,661

Impairment (Released) charges of non current assets held for sale

(312,731)

-

 

Operating profits before changes in operating assets and liabilities

 

2,808,362

2,100,145

Net decrease (increase) in assets and liabilities

Due from banks

(6,369,580)

(5,624,857)

Treasury bills and other governmental notes

(1,278,538)

3,942,273

Trading financial assets

284,970

686,027

Derivative financial instruments

6,832

(87,486)

Loans and advances to banks and customers

(1,095,248)

(3,899,476)

Other assets

(739,325)

425,985

Non Current Assets Held for Sale

188,136

-

Due to banks

(410,928)

(971,815)

Due to customers

7,765,546

14,118,360

Income tax obligations paid

(2,017,034)

(1,949,694)

Other liabilities

1,624,858

1,592,521

Net cash provided from operating activities

768,051

10,331,983

Cash flow from investing activities

Proceeds from selling subsidiary and associates

-

159,989

Payment for purchases of property, plant, equipment and branches constructions

(204,805)

(174,558)

Proceeds from redemption of held to maturity financial investments

7,111,107

1,311

Payment for purchases of held to maturity financial investments

(2,575,231)

-

Payment for purchases of available for sale financial investments

(153,395)

(129,845)

Proceeds from selling available for sale financial investments

480,343

2,332,077

Proceeds from selling non current assets held for sale

500,867

-

Net cash used in investing activities

5,158,886

2,188,974

Cash flow from financing activities

Increase (decrease) in long term loans

(5,025)

(7,094)

Dividend paid

(773,274)

(1,463,450)

Net cash used in financing activities

(778,299)

(1,470,544)

 

Net increase (decrease) in cash and cash equivalent during the period

5,148,638

11,050,413

Beginning balance of cash and cash equivalent

61,518,700

22,433,117

Cash and cash equivalent at the end of the period

66,667,338

33,483,530

Cash and cash equivalent comprise:

Cash and balances with central bank

15,101,163

16,409,342

Due from banks

65,449,817

31,110,134

Treasury bills and other governmental notes

39,956,034

18,194,950

Obligatory reserve balance with CBE

(10,066,100)

(13,893,058)

Due from banks with maturities more than three months

(4,307,610)

(149,940)

Treasury bills with maturity more than three months

(39,465,966)

(18,187,898)

Total cash and cash equivalent

66,667,338

33,483,530

 

Separate statement of changes in shareholders' equity for the period ended March 31, 2016

 

Mar. 31, 2016

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

 

EGP Thousands

 

Beginning balance

11,470,603

803,355

1,518,525

30,214

(2,202,463)

2,513

4,640,718

248,148

16,511,613

 

Transferred to reserves

-

232,008

2,944,190

564

-

-

(3,176,762)

-

-

 

Dividend paid

-

-

-

-

-

-

(1,463,450)

-

(1,463,450)

 

Net profit for the period

-

-

-

-

-

-

1,328,712

-

1,328,712

 

Net unrealised gain/(loss) on AFS

-

-

-

-

(1,873,055)

-

-

-

(1,873,055)

 

Transferred (from) to bank risk reserve

-

-

-

-

-

506

(506)

-

-

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

48,661

48,661

 

Balance at the end of the period

11,470,603

1,035,363

4,462,715

30,778

(4,075,518)

3,019

1,328,712

296,809

14,552,481

 

 

Separate statement of changes in shareholders' equity for the period ended March 31, 2017

 

Mar. 31, 2017

Issued and paid up capital

Legal reserve

General reserve

Special reserve

Reserve For A.F.S investments revaluation diff.

Banking risks reserve

Net profit for the period

Reserve for employee stock ownership plan

Total

 

EGP Thousands

 

Beginning balance

11,538,660

1,035,363

4,554,403

30,778

(2,180,244)

3,019

5,950,555

343,460

21,275,994

 

Transferred to reserves

-

297,444

4,300,607

1,682

-

-

(4,599,733)

-

-

 

Dividend paid

-

-

-

-

-

-

(1,350,207)

-

(1,350,207)

 

Net profit for the period

-

-

-

-

-

-

1,785,442

-

1,785,442

 

Net unrealised gain/(loss) on AFS

-

-

-

-

218,228

-

-

-

218,228

 

Transferred (from) to bank risk reserve

-

-

-

-

-

615

(615)

-

-

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

77,104

77,104

 

Balance at the end of the period

11,538,660

1,332,807

8,855,010

32,460

(1,962,016)

3,634

1,785,442

420,564

22,006,561

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFFMGMKKGLGNZM
Date   Source Headline
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 20227:00 amRNSInvitation toCIB Ordinary General Assembly Meeting
22nd Feb 20227:00 amRNSCIB FY 2021 Separate Financial results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.